132 related articles for article (PubMed ID: 7186645)
21. Post-parathyroidectomy serum phosphate kinetics is peculiar to female hemodialysis patients with a high body mass index.
Lomonte C; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Basile C
J Nephrol; 2006; 19(1):70-6. PubMed ID: 16523429
[TBL] [Abstract][Full Text] [Related]
22. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
23. High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction.
Kario K; Matsuo T; Kobayashi H; Matsuo M; Asada R; Koide M
Thromb Haemost; 1995 Oct; 74(4):1020-4. PubMed ID: 8560404
[TBL] [Abstract][Full Text] [Related]
24. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients.
Khedmat H; Ahmadzad-Asl M; Amini M; Lessan-Pezeshki M; Einollahi B; Pourfarziani V; Naseri MH; Davoudi F
Transplant Proc; 2007 May; 39(4):1003-7. PubMed ID: 17524875
[TBL] [Abstract][Full Text] [Related]
25. [Serum protein values in uremic patients, dialysis-patients and patients with transplanted kidneys].
Marone C; Flury W; Frey F; Keller H
Schweiz Med Wochenschr; 1977 Jul; 107(30):1066-72. PubMed ID: 331471
[TBL] [Abstract][Full Text] [Related]
26. Rubidium deficiency in dialysis patients.
Canavese C; DeCostanzi E; Branciforte L; Caropreso A; Nonnato A; Pietra R; Fortaner S; Jacono F; Angelini G; Gallieni M; Fop F; Sabbioni E
J Nephrol; 2001; 14(3):169-75. PubMed ID: 11439740
[TBL] [Abstract][Full Text] [Related]
27. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients.
Soejima A; Matsuzawa N; Miyake N; Karube M; Fukuoka K; Nakabayashi K; Kitamoto K; Nagasawa T
Clin Nephrol; 1999 Feb; 51(2):92-7. PubMed ID: 10069644
[TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
29. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-8 in chronic renal failure and dialysis patients.
Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y
Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257
[TBL] [Abstract][Full Text] [Related]
31. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
32. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
33. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
34. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
Shahbazian H; Zand Moghadam A; Ehsanpour A; Khazaali M
Iran J Kidney Dis; 2009 Jul; 3(3):151-5. PubMed ID: 19617664
[TBL] [Abstract][Full Text] [Related]
35. Problems in adaptation to maintenance hemodialysis. A four-year study of 25 patients.
Reichsman F; Levy NB
Arch Intern Med; 1972 Dec; 130(6):859-65. PubMed ID: 5082466
[No Abstract] [Full Text] [Related]
36. Elevation of serum levels of beta-aminoisobutyric acid in uremic patients and the toxicity of the amino acid.
Gejyo F; Kinoshita Y; Ikenaka T
Clin Nephrol; 1977 Dec; 8(6):520-5. PubMed ID: 598058
[TBL] [Abstract][Full Text] [Related]
37. [Cholesterol-HDL and apoprotein A in a group of chronic uremic patients undergoing continuing hemodialytic treatment].
Bergesio F; Ciuti R; Manfredi M; Frizzi V; Zerboni R
Minerva Nefrol; 1983; 30(3):165-73. PubMed ID: 6646491
[No Abstract] [Full Text] [Related]
38. [Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients].
Giacchino F; Giachino G; Giraudo G; Boero R; Basolo B; Bancale E; Nigra M; Piccoli GB; Piccoli G
Arch Sci Med (Torino); 1982; 139(1):19-22. PubMed ID: 7103704
[TBL] [Abstract][Full Text] [Related]
39. Serum endorphin levels in uremic patients under maintenance hemodialysis.
Hwang JC; Hsu KT; Tsai HC; Lam KK; Wang PW
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):360-5. PubMed ID: 2529347
[TBL] [Abstract][Full Text] [Related]
40. Middle molecular weight substances in the cerebrospinal fluid of uremic patients.
Sperschneider H; Spustova V; Stein G; Dzurik R
Clin Nephrol; 1982 Jun; 17(6):298-302. PubMed ID: 7105504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
